Science leaders urge diabetes patients to talk with doctor before making changes to medication use
Thursday, July 15, 2010 - 13:49
in Health & Medicine
The Endocrine Society, American Diabetes Association and American Association of Clinical Endocrinologists issue joint statement in response to an FDA panel's recommendation to keep rosiglitazone (Avandia) on the market